Related Experiment Videos

Proteus species isolated from human eyes

Insights

Gentamicin effectively controlled Proteus eye infections, including Proteus mirabilis and Proteus morganii. Both in vitro and in vivo studies confirmed gentamicin

Area of Science:

  • Ophthalmology
  • Microbiology
  • Infectious Diseases

Background:

  • Proteus species are opportunistic pathogens that can cause serious eye infections.
  • Understanding the prevalence and antibiotic susceptibility of Proteus in ocular infections is crucial for effective treatment.

Purpose of the Study:

  • To identify the species of Proteus isolated from human eye infections.
  • To evaluate the in vitro and in vivo efficacy of antibiotics, particularly gentamicin, against these isolates.

Main Methods:

  • Isolation and identification of Proteus species from human ocular samples.
  • In vitro antibiotic sensitivity testing of Proteus isolates.
  • In vivo efficacy study using experimental Proteus keratitis in rabbits treated with gentamicin and tobramycin.

Main Results:

  • Proteus mirabilis (85%) and Proteus morganii (15%) were the predominant species isolated.
  • Gentamicin demonstrated superior in vitro activity against both P. mirabilis and P. morganii compared to other tested antibiotics.
  • In vivo, gentamicin and tobramycin showed comparable clinical outcomes in rabbit keratitis, but gentamicin was more effective in microbial eradication.

Conclusions:

  • Proteus mirabilis and Proteus morganii are significant causes of bacterial keratitis.
  • Gentamicin is a highly effective antibiotic for treating Proteus ocular infections, offering superior eradication potential in vivo.

Related Concept Videos